Full-Time

Univ – Research Protocol Writer

Hollings Cancer Center

Posted on 11/21/2024

Medical University of South Carolina

Medical University of South Carolina

Compensation Overview

$56.2k - $104kAnnually

Mid

Charlotte, NC, USA

Category
Editing & Proofreading
Technical Writing
Content & Writing
Requirements
  • A bachelor's degree
  • three years relevant program experience
  • knowledgeable in Good Clinical Practice Guidelines
  • knowledge of the Code of Federal Regulations
Responsibilities
  • oversee pipeline and activation of all MUSC investigator initiated therapeutic clinical trials
  • ensure that HCC IITs are prepared and implemented according to Good Clinical Practice guidelines and federal, state, and local requirements
  • conduct administrative duties associated with the sponsor responsibilities of HCC IITs
  • develop documents to guide the conduct of investigator-initiated clinical research (protocols, source documents, and data collection forms)
  • project management of the start-up process
  • compiling, helping write, and maintaining the FDA IND application
  • provides support to the SISU Assistant Director and the scientific leaders of the Hollings Advisory for Rapid Translation (HART) in managing the intake of new MUSC investigator oncology trial concepts
  • works with SISU Director and HART leadership to prioritize submissions based on established criteria per institutional and NCI guidelines
  • administers monthly and ad hoc concept meetings for the active monitoring of timely progress of concept review and development from intake until abandonment or trial activation
  • consults with principal and co-investigators, biostatisticians, translational lab scientists, and leaders of HART to supporting the growth of the HCC IIT pipeline
  • conducts literary searches of publications related to trial concepts and may support the drafting of background and rationale
  • utilizes approved tools for trial development
  • searches CTO.gov trial listings and reviews other past trial documents to support the protocol writing of new HCC investigator-initiated trial (IIT) protocols
  • supports the drafting and editing of the protocol, informed consent, and other study specific documents such as but not limited to patient questionnaires, drug diaries, and trial summaries
  • reviews Investigator Brochures (IB) and package inserts to help draft drug administration, the risk profile, safety assessment language, study calendar and drug administration tables of a protocol document
  • utilizes the appropriate model documents for protocol documents, informed consent, regulatory and patient data collection instruments to support the rapid activation of new IITs
  • organizes collaborative meetings and follows HCC policies regarding new trial intake and document management
  • records study status updates in a detailed, accurate and timely manner within the appropriate CTO systems (e.g. OnCore, eReg, etc.)
  • assures accurate status communication of trial concepts and activation milestones within Pending projects meeting forums and other reporting requests
  • escalates delays in a professional and timely manner and supports corrective action initiatives
  • serves as the regulatory specialist to complete the Food and Drug Administration (FDA) Investigational New Drug (IND) application and Institutional Review Board (IRB) applications
  • works very closely with the PI, HCC Biostatistics Shared Resource, CTO study team and other relevant stakeholders in the development and activation process of new HCC IITs
  • ensures that each protocol follows that standard CTO activation process with assurance that the IIT is vetted by the clinical program managers, ancillary providers, and finance for trial feasibility
  • creates and revises study documents and applications per investigator, study team, HCC Protocol Review Committee (PRC) and MUSC institutional Review Board (IRB), and Food and Drug Administration (FDA) requirements
  • collaborates with investigational pharmacy and drug provider to develop pharmacy manuals and protocol drug sections
  • responsible for the development and implementation of study specific data safety monitoring plans
  • coordinates and participates in team meetings with investigators and support staff as indicated to focus on the development and activation of the IIT
  • follows the CTO task lists for study activation and participates with timely updates within internal CTO meetings to report on the activation statuses
  • maintains and manages electronic study files for IITs
  • receives amendment requests from the SISU program coordinators and PI and tracks these changes within the development of new protocol, informed consent, or other IRB approved materials
  • creates the marked and clean copy changes and submits the changes to the IRB or record and FDA IND as applicable
  • creates an accurate summary of changes document and maintains a system of proper version control and effective release date records
  • maintains the Trial master file and properly communicates to the other SISU members, PI, biostats, lab, and other protocol stakeholders the amendment status, changes and implementation
  • provides administrative support of the HCC Advisory for Rapid Translation (HART) and any concept development meeting that includes taking minutes, scheduling meetings and preparing and presenting agenda items
  • provides project management of special activities
Medical University of South Carolina

Medical University of South Carolina

View

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A